Alpha-Mangostin Alleviates the Short-term 6-Hydroxydopamine-Induced Neurotoxicity and Oxidative Damage in Rat Cortical Slices and in Caenorhabditis elegans


Estrada-Valencia R., Ester Hurtado-Diaz M., Rangel-Lopez E., Retana-Marquez S., Tunez I., Tinkov A., ...More

NEUROTOXICITY RESEARCH, vol.40, pp.573-584, 2022 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 40
  • Publication Date: 2022
  • Doi Number: 10.1007/s12640-022-00493-8
  • Title of Journal : NEUROTOXICITY RESEARCH
  • Page Numbers: pp.573-584
  • Keywords: Alpha-mangostin, Antioxidant defense, 6-Hydroxydopamine, Neurotoxicity, C, elegans, SKN-1, QUINOLINIC ACID, SKN-1, INFLAMMATION, MODULATION, XANTHONES

Abstract

The development, at the experimental level, of therapeutic strategies based on natural products to attenuate neurological alterations in degenerative disorders has gained attention. Antioxidant molecules exhibit both anti-inflammatory and neuroprotective properties. Alpha-mangostin (alpha-Man) is a natural xanthonoid isolated from the mangosteen tree with demonstrated antioxidant and cytoprotective properties. In this study, we investigated the antioxidant and protective properties of alpha-Man, both ex vivo and in vivo. We assessed the mitochondrial reductant capacity and oxidative damage to lipids in rat cortical slices, and several endpoints characteristic of physiological stress in the nematode, Caenorhabditis elegans (C. elegans), upon exposure to the parkinsonian neurotoxin, 6-hydroxydopamine (6-OHDA). In rat cortical slices, alpha-Man (25 and 50 mu M) reduced the 6-OHDA (100 mu M)-induced oxidative damage to lipid levels, but failed to reverse loss in cell viability. In wild-type (N2) C. elegans, alpha-Man (5-100 mu M) protected against 6-OHDA (25 mM)-induced decrease in survival when administered either as pre- or post-treatment. Protective effects of alpha-Man were also observed on survival in the VC1772 strain (skn-1 KO-) exposed to 6-OHDA, though the extent of the protection was lesser than in the wild-type N2 strain. However, alpha-Man (5-50 mu M) failed to attenuate the 6-OHDA-induced motor alterations in the N2 strain. The loss of lifespan induced by 6-OHDA in the N2 strain was fully reversed by high concentrations of alpha-Man. In addition, while 6-OHDA decreased the expression of glutathione S-transferase in the CL2166 C. elegans strain, alpha-Man preserved and stimulated the expression of this protein. alpha-Man (25 mu M) also prevented 6-OHDA-induced dopaminergic neurodegeneration in the BZ555 C. elegans strain. Altogether, our novel results suggest that alpha-Man affords partial protection against several, but not all, short-term toxic effects induced by 6-OHDA in cortical slices and in a skn-1-dependent manner in C. elegans.